Tag: Pexa-Vec
Phase 3 trial of Pexa-Vec for advanced liver cancer initiated in China
South Korean biotech company SillaJen and Hong Kong-based Lee's Pharmaceutical have enrolled the first patient in China for a phase 3 trial called PHOCUS which ... Read More